Liver Disorders: Hepatitis, Cirrhosis, NAFLD, Liver Cancer & Autoimmune Liver Disease

Overview

This page covers the major categories of liver disease encountered in clinical practice.

Viral hepatitis (A through E) refers to liver inflammation caused by different viruses with different transmission routes — hepatitis A and E spread through contaminated food or water and are usually self-limiting; hepatitis B and C spread through blood or bodily fluids and can become chronic, potentially progressing to cirrhosis or liver cancer if untreated. Effective vaccines exist for hepatitis A and B, and antiviral therapies can control hepatitis B and cure most cases of hepatitis C.

Cirrhosis is advanced scarring of the liver from any long-standing cause (viral hepatitis, alcohol, NAFLD/NASH, autoimmune or cholestatic disease). It can lead to portal hypertension, fluid buildup (ascites), enlarged veins at risk of bleeding (varices), and confusion from toxin buildup (hepatic encephalopathy). Severity is tracked with tools such as the Child-Pugh and MELD scores.

Non-alcoholic fatty liver disease (NAFLD) and its more advanced form, non-alcoholic steatohepatitis (NASH), involve fat accumulation in the liver, often linked to obesity, insulin resistance, and metabolic syndrome. NASH involves inflammation and can progress to fibrosis and cirrhosis over time.

Liver cancer, most commonly hepatocellular carcinoma (HCC), typically arises in a liver already damaged by cirrhosis from any cause and is monitored for using imaging and blood markers such as AFP.

Autoimmune hepatitis and cholestatic diseases (primary biliary cholangitis and primary sclerosing cholangitis) occur when the immune system attacks liver cells or bile ducts, requiring immunosuppressive or bile-acid-modifying medications.

Nutritional Considerations

NAFLD/NASH: This is the liver condition with the strongest direct nutrition lever. Gradual, sustained weight loss (commonly cited target of roughly 7–10% of body weight, achieved gradually) along with a Mediterranean-style eating pattern — emphasizing vegetables, whole grains, lean protein, and unsaturated fats while limiting added sugars (especially fructose-sweetened beverages) and refined carbohydrates — is the primary evidence-based intervention, per AASLD guidance. Regular physical activity supports the same goal.

Viral hepatitis: No special diet cures hepatitis, but a balanced diet supports liver function during and after antiviral treatment. People with chronic hepatitis B or C are generally advised to avoid or strictly limit alcohol, since it accelerates liver damage.

Cirrhosis: Nutritional needs shift with disease severity and are best managed by a physician and dietitian together. Malnutrition is common in cirrhosis and adequate protein and calorie intake is generally protective — patients are usually not told to broadly restrict protein, contrary to older practice, except in specific circumstances directed by their care team. When ascites is present, a physician may recommend a reduced-sodium diet to help manage fluid retention; the specific sodium target should come from the treating clinician, not a generic threshold.

Liver cancer: Nutrition support focuses on maintaining adequate protein and calorie intake through treatment, since cancer and cirrhosis together increase the risk of malnutrition and muscle loss (sarcopenia). This should be managed by an oncology dietitian working with the hepatology and oncology team.

Autoimmune and cholestatic liver disease: No specific diet treats these conditions; general liver-supportive nutrition applies. When cholestasis significantly reduces bile flow, absorption of fat-soluble vitamins (A, D, E, K) can be impaired, and a physician may check levels and recommend supplementation if deficiency is confirmed.

Safety

Liver disease severity varies enormously, from stable and asymptomatic to life-threatening. Any diet changes — including sodium or protein restriction, weight loss goals, or vitamin supplementation — should be guided by the treating hepatologist or gastroenterologist and a registered dietitian, since inappropriate restriction can cause harm (for example, unnecessary protein restriction can worsen malnutrition in cirrhosis).

Sources

• National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH — Liver Disease, NAFLD/NASH, Cirrhosis, Viral Hepatitis
• American Association for the Study of Liver Diseases (AASLD) practice guidance
• Centers for Disease Control and Prevention (CDC) — Viral Hepatitis

Frequently Asked Questions

Q1: What is the single most evidence-backed dietary change for fatty liver disease?

A1: Gradual weight loss through a balanced, Mediterranean-style eating pattern combined with regular physical activity has the strongest evidence base for improving NAFLD/NASH, according to AASLD guidance.

Q2: Should people with cirrhosis restrict protein?

A2: Generally no — adequate protein intake is now recommended for most people with cirrhosis to prevent malnutrition and muscle loss, a shift from older practice. Any protein restriction should only be applied under specific direction from the treating care team.

Q3: When should someone with liver disease see a specialist urgently?

A3: New or worsening jaundice, confusion, abdominal swelling, vomiting blood, or black stools are signs that warrant urgent medical evaluation.

[!IMPORTANT] This content is educational and not medical advice. Liver disease requires diagnosis and ongoing management by a physician, typically a hepatologist or gastroenterologist.